Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | RARB | P10826 | 4/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | RARA | P10276 | 2/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22011104 | 0.86 | NAAA (0.33) | MAOBRARBNAAARARARARG | |
| SCHEMBL22011002 | 0.85 | L3MBTL1 (0.38) | NAAA | |
| SCHEMBL22011802 | 0.81 | CTSL (0.38) | — | |
| SCHEMBL22011189 | 0.79 | RARB (0.37) | RARBRARARARG | |
| SCHEMBL22011181 | 0.78 | PGAM1 (0.42) | MAOBMAOAABCB1PGAM1 | |
| SCHEMBL10301559 | 0.76 | CNR2 (0.41) | RARBRARARARG | |
| SCHEMBL22010998 | 0.76 | RARB (0.44) | RARBABCB1RARARARG | |
| SCHEMBL22010820 | 0.76 | RARB (0.40) | RARBABCB1PGAM1 | |
| SCHEMBL22011081 | 0.75 | MAOB (0.36) | MAOBMAOAABCB1 | |
| SCHEMBL424417 | 0.74 | NAAA (0.40) | RARBNAAARARARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | MAOB 787/4885MAOA 1418/4885RARB 2226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.